✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Alteogen Inc

Common Name
Alteogen
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
Employees
159
Ticker
196170
Exchange
KOREA EXCHANGE
Description
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth horm...

Alteogen's Revenues Data

Explore Alteogen's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
149,482,301a
₩215,859 million
70,093,581a
₩102,855 million
75,536,009a
₩96,523 million
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Alteogen’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Alteogen's Annual Report 2025